Hong Kong
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -596.26 M
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
|
2 |
USD -401.08 M
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
3 |
USD -239.97 M
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
4 |
USD -205.91 M
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
5 |
USD -90.12 M
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
6 |
USD -68.82 M
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
7 |
USD -54.27 M
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
8 |
USD -44.78 M
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
9 |
USD -32.61 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
10 |
USD -29.86 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
11 |
USD -21.15 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
12 |
USD -20.45 M
|
Dec. 31, 2023 | USD 0.52 | 0.23% |
|
Hong Kong |
|
13 |
USD -20.45 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
14 |
USD -14.63 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
15 |
USD -7.48 M
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
16 |
USD -6.92 M
|
March 31, 2024 | USD 0.27 | 0.46% |
|
Hong Kong |
|
17 |
USD -4.48 M
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
18 |
USD -3.15 M
|
March 31, 2024 | USD 0.46 | 4.31% |
|
Hong Kong |
|
19 |
USD -2.80 M
|
Dec. 31, 2023 | USD 1.07 | 3.09% |
|
Hong Kong |
|
20 |
USD -1.74 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
21 |
USD -911.81 K
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
22 |
USD -497.01 K
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
23 |
USD -5.38 K
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Capital Expenditure is BeiGene, Ltd. (HKSE: 6160.HK) at USD -596.26 M.
The Healthcare company in Hong Kong with the lowest Capital Expenditure is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD -5.38 K.
The top 10 Healthcare companies in Hong Kong by Capital Expenditure are BeiGene, Ltd., China Resources Pharmaceutical Group Limited, Sino Biopharmaceutical Limited, The United Laboratories International Holdings Limited, SSY Group Limited, China Traditional Chinese Medicine Holdings Co. Limited, Guangdong Hybribio Biotech Co.,Ltd., China Medical System Holdings Limited, HUTCHMED (China) Limited and Dawnrays Pharmaceutical (Holdings) Limited.
The bottom 10 Healthcare companies in Hong Kong by Capital Expenditure are Regencell Bioscience Holdings Limited, Tycoon Group Holdings Limited, Prenetics Global Limited, Sirnaomics Ltd., Beijing Tong Ren Tang Chinese Medicine Company Limited, Alibaba Health Information Technology Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Perfect Medical Health Management Limited, OrbusNeich Medical Group Holdings Limited and SinoMab BioScience Limited.